Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma

Background Decrease in skeletal muscle mass and function, known as sarcopenia, is associated with poor prognosis. Visceral fat accumulation also is related to mortality. This study investigated the impact of preoperative skeletal muscle mass, muscle quality, and visceral adiposity on outcomes in pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of surgical oncology 2017-04, Vol.24 (4), p.1037-1045
Hauptverfasser: Okumura, Shinya, Kaido, Toshimi, Hamaguchi, Yuhei, Kobayashi, Atsushi, Shirai, Hisaya, Fujimoto, Yasuhiro, Iida, Taku, Yagi, Shintaro, Taura, Kojiro, Hatano, Etsuro, Okajima, Hideaki, Uemoto, Shinji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1045
container_issue 4
container_start_page 1037
container_title Annals of surgical oncology
container_volume 24
creator Okumura, Shinya
Kaido, Toshimi
Hamaguchi, Yuhei
Kobayashi, Atsushi
Shirai, Hisaya
Fujimoto, Yasuhiro
Iida, Taku
Yagi, Shintaro
Taura, Kojiro
Hatano, Etsuro
Okajima, Hideaki
Uemoto, Shinji
description Background Decrease in skeletal muscle mass and function, known as sarcopenia, is associated with poor prognosis. Visceral fat accumulation also is related to mortality. This study investigated the impact of preoperative skeletal muscle mass, muscle quality, and visceral adiposity on outcomes in patients undergoing resection of intrahepatic cholangiocarcinoma (ICC). Methods A retrospective analysis was performed of 109 patients undergoing resections of ICC between January 2004 and April 2015. Skeletal muscle mass [skeletal muscle index (SMI)], skeletal muscle quality [muscle attenuation (MA)], and visceral adiposity [visceral to subcutaneous adipose tissue area ratio (VSR)] were measured on preoperative computed tomography images. The impacts of these parameters on outcomes after ICC resections were analyzed. Results The overall survival rates were significantly lower in patients with low SMI ( P  = 0.002), low MA ( P  = 0.032), and high VSR ( P  = 0.026) compared with patients with high SMI, high MA, and low VSR, respectively. With multivariate analyses, in patients with stage I–III, low SMI (hazard ratio (HR) 3.29, P  = 0.003) and low MA (HR 2.86, P  = 0.010) were revealed as independent significant risk factors for mortality. In patients with stage IV, none of these parameters was identified as risk factors, with only the absence of adjuvant chemotherapy identified as an independent risk factor for mortality (HR 5.92, P  = 0.001). Conclusions Although stage was the most important factor, low skeletal muscle mass and quality were closely related to mortality after resection of ICC in patients with stage I–III.
doi_str_mv 10.1245/s10434-016-5668-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1839121441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1839121441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-f628102280c361b711355c95aa083ed40e5a5ecb00260bc244a30a3406320fb73</originalsourceid><addsrcrecordid>eNp1kc1O3DAUhS1UBJTyAGyQpW66IHD9m8wSjUo7EghBW7aW43EGUycOtqOKR-hb19FAVVViZfvc7557rYPQMYEzQrk4TwQ44xUQWQkpm4rtoAMiisJlQ96VOxRxQaXYR-9TegQgNQOxh_Zp3bCaLuoD9HvVj9pkHDr87af1NmuPr6dkvMXXOqXT18ftpL3Lz6dYD2t875KxsZAXazeGVHQcBnwzZRN6m_Bl8D78csMG39lkTXalWPxXQ476wY46O4OXD8HrYeOC0dG4IfT6A9rttE_26OU8RD8uP39ffq2ubr6slhdXleGsyVUnaUOA0gYMk6StCWFCmIXQGhpm1xys0MKaFoBKaA3lXDPQjINkFLq2Zofo09Z3jOFpsimrfv6OL-vYMCVFGrYglHBOCvrxP_QxTHEo2xWq5vMmjBWKbCkTQ0rRdmqMrtfxWRFQc05qm5MqOak5JzX3nLw4T21v1387XoMpAN0CqZSGjY3_jH7T9Q_I3J19</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1874628133</pqid></control><display><type>article</type><title>Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Okumura, Shinya ; Kaido, Toshimi ; Hamaguchi, Yuhei ; Kobayashi, Atsushi ; Shirai, Hisaya ; Fujimoto, Yasuhiro ; Iida, Taku ; Yagi, Shintaro ; Taura, Kojiro ; Hatano, Etsuro ; Okajima, Hideaki ; Uemoto, Shinji</creator><creatorcontrib>Okumura, Shinya ; Kaido, Toshimi ; Hamaguchi, Yuhei ; Kobayashi, Atsushi ; Shirai, Hisaya ; Fujimoto, Yasuhiro ; Iida, Taku ; Yagi, Shintaro ; Taura, Kojiro ; Hatano, Etsuro ; Okajima, Hideaki ; Uemoto, Shinji</creatorcontrib><description>Background Decrease in skeletal muscle mass and function, known as sarcopenia, is associated with poor prognosis. Visceral fat accumulation also is related to mortality. This study investigated the impact of preoperative skeletal muscle mass, muscle quality, and visceral adiposity on outcomes in patients undergoing resection of intrahepatic cholangiocarcinoma (ICC). Methods A retrospective analysis was performed of 109 patients undergoing resections of ICC between January 2004 and April 2015. Skeletal muscle mass [skeletal muscle index (SMI)], skeletal muscle quality [muscle attenuation (MA)], and visceral adiposity [visceral to subcutaneous adipose tissue area ratio (VSR)] were measured on preoperative computed tomography images. The impacts of these parameters on outcomes after ICC resections were analyzed. Results The overall survival rates were significantly lower in patients with low SMI ( P  = 0.002), low MA ( P  = 0.032), and high VSR ( P  = 0.026) compared with patients with high SMI, high MA, and low VSR, respectively. With multivariate analyses, in patients with stage I–III, low SMI (hazard ratio (HR) 3.29, P  = 0.003) and low MA (HR 2.86, P  = 0.010) were revealed as independent significant risk factors for mortality. In patients with stage IV, none of these parameters was identified as risk factors, with only the absence of adjuvant chemotherapy identified as an independent risk factor for mortality (HR 5.92, P  = 0.001). Conclusions Although stage was the most important factor, low skeletal muscle mass and quality were closely related to mortality after resection of ICC in patients with stage I–III.</description><identifier>ISSN: 1068-9265</identifier><identifier>EISSN: 1534-4681</identifier><identifier>DOI: 10.1245/s10434-016-5668-3</identifier><identifier>PMID: 27837297</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Aged ; Area Under Curve ; Bile Duct Neoplasms - pathology ; Bile Duct Neoplasms - surgery ; Bile Ducts, Intrahepatic ; Cholangiocarcinoma - pathology ; Cholangiocarcinoma - surgery ; Disease-Free Survival ; Female ; Hepatobiliary Tumors ; Humans ; Intra-Abdominal Fat - diagnostic imaging ; Male ; Medicine ; Medicine &amp; Public Health ; Middle Aged ; Multidetector Computed Tomography ; Muscle, Skeletal - diagnostic imaging ; Muscle, Skeletal - physiopathology ; Neoplasm Staging ; Oncology ; Preoperative Period ; Retrospective Studies ; Risk Factors ; ROC Curve ; Surgery ; Surgical Oncology ; Survival Rate ; Treatment Outcome</subject><ispartof>Annals of surgical oncology, 2017-04, Vol.24 (4), p.1037-1045</ispartof><rights>Society of Surgical Oncology 2016</rights><rights>Annals of Surgical Oncology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-f628102280c361b711355c95aa083ed40e5a5ecb00260bc244a30a3406320fb73</citedby><cites>FETCH-LOGICAL-c438t-f628102280c361b711355c95aa083ed40e5a5ecb00260bc244a30a3406320fb73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1245/s10434-016-5668-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1245/s10434-016-5668-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27837297$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Okumura, Shinya</creatorcontrib><creatorcontrib>Kaido, Toshimi</creatorcontrib><creatorcontrib>Hamaguchi, Yuhei</creatorcontrib><creatorcontrib>Kobayashi, Atsushi</creatorcontrib><creatorcontrib>Shirai, Hisaya</creatorcontrib><creatorcontrib>Fujimoto, Yasuhiro</creatorcontrib><creatorcontrib>Iida, Taku</creatorcontrib><creatorcontrib>Yagi, Shintaro</creatorcontrib><creatorcontrib>Taura, Kojiro</creatorcontrib><creatorcontrib>Hatano, Etsuro</creatorcontrib><creatorcontrib>Okajima, Hideaki</creatorcontrib><creatorcontrib>Uemoto, Shinji</creatorcontrib><title>Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma</title><title>Annals of surgical oncology</title><addtitle>Ann Surg Oncol</addtitle><addtitle>Ann Surg Oncol</addtitle><description>Background Decrease in skeletal muscle mass and function, known as sarcopenia, is associated with poor prognosis. Visceral fat accumulation also is related to mortality. This study investigated the impact of preoperative skeletal muscle mass, muscle quality, and visceral adiposity on outcomes in patients undergoing resection of intrahepatic cholangiocarcinoma (ICC). Methods A retrospective analysis was performed of 109 patients undergoing resections of ICC between January 2004 and April 2015. Skeletal muscle mass [skeletal muscle index (SMI)], skeletal muscle quality [muscle attenuation (MA)], and visceral adiposity [visceral to subcutaneous adipose tissue area ratio (VSR)] were measured on preoperative computed tomography images. The impacts of these parameters on outcomes after ICC resections were analyzed. Results The overall survival rates were significantly lower in patients with low SMI ( P  = 0.002), low MA ( P  = 0.032), and high VSR ( P  = 0.026) compared with patients with high SMI, high MA, and low VSR, respectively. With multivariate analyses, in patients with stage I–III, low SMI (hazard ratio (HR) 3.29, P  = 0.003) and low MA (HR 2.86, P  = 0.010) were revealed as independent significant risk factors for mortality. In patients with stage IV, none of these parameters was identified as risk factors, with only the absence of adjuvant chemotherapy identified as an independent risk factor for mortality (HR 5.92, P  = 0.001). Conclusions Although stage was the most important factor, low skeletal muscle mass and quality were closely related to mortality after resection of ICC in patients with stage I–III.</description><subject>Aged</subject><subject>Area Under Curve</subject><subject>Bile Duct Neoplasms - pathology</subject><subject>Bile Duct Neoplasms - surgery</subject><subject>Bile Ducts, Intrahepatic</subject><subject>Cholangiocarcinoma - pathology</subject><subject>Cholangiocarcinoma - surgery</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Hepatobiliary Tumors</subject><subject>Humans</subject><subject>Intra-Abdominal Fat - diagnostic imaging</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Middle Aged</subject><subject>Multidetector Computed Tomography</subject><subject>Muscle, Skeletal - diagnostic imaging</subject><subject>Muscle, Skeletal - physiopathology</subject><subject>Neoplasm Staging</subject><subject>Oncology</subject><subject>Preoperative Period</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>ROC Curve</subject><subject>Surgery</subject><subject>Surgical Oncology</subject><subject>Survival Rate</subject><subject>Treatment Outcome</subject><issn>1068-9265</issn><issn>1534-4681</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kc1O3DAUhS1UBJTyAGyQpW66IHD9m8wSjUo7EghBW7aW43EGUycOtqOKR-hb19FAVVViZfvc7557rYPQMYEzQrk4TwQ44xUQWQkpm4rtoAMiisJlQ96VOxRxQaXYR-9TegQgNQOxh_Zp3bCaLuoD9HvVj9pkHDr87af1NmuPr6dkvMXXOqXT18ftpL3Lz6dYD2t875KxsZAXazeGVHQcBnwzZRN6m_Bl8D78csMG39lkTXalWPxXQ476wY46O4OXD8HrYeOC0dG4IfT6A9rttE_26OU8RD8uP39ffq2ubr6slhdXleGsyVUnaUOA0gYMk6StCWFCmIXQGhpm1xys0MKaFoBKaA3lXDPQjINkFLq2Zofo09Z3jOFpsimrfv6OL-vYMCVFGrYglHBOCvrxP_QxTHEo2xWq5vMmjBWKbCkTQ0rRdmqMrtfxWRFQc05qm5MqOak5JzX3nLw4T21v1387XoMpAN0CqZSGjY3_jH7T9Q_I3J19</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Okumura, Shinya</creator><creator>Kaido, Toshimi</creator><creator>Hamaguchi, Yuhei</creator><creator>Kobayashi, Atsushi</creator><creator>Shirai, Hisaya</creator><creator>Fujimoto, Yasuhiro</creator><creator>Iida, Taku</creator><creator>Yagi, Shintaro</creator><creator>Taura, Kojiro</creator><creator>Hatano, Etsuro</creator><creator>Okajima, Hideaki</creator><creator>Uemoto, Shinji</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170401</creationdate><title>Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma</title><author>Okumura, Shinya ; Kaido, Toshimi ; Hamaguchi, Yuhei ; Kobayashi, Atsushi ; Shirai, Hisaya ; Fujimoto, Yasuhiro ; Iida, Taku ; Yagi, Shintaro ; Taura, Kojiro ; Hatano, Etsuro ; Okajima, Hideaki ; Uemoto, Shinji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-f628102280c361b711355c95aa083ed40e5a5ecb00260bc244a30a3406320fb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Area Under Curve</topic><topic>Bile Duct Neoplasms - pathology</topic><topic>Bile Duct Neoplasms - surgery</topic><topic>Bile Ducts, Intrahepatic</topic><topic>Cholangiocarcinoma - pathology</topic><topic>Cholangiocarcinoma - surgery</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Hepatobiliary Tumors</topic><topic>Humans</topic><topic>Intra-Abdominal Fat - diagnostic imaging</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Middle Aged</topic><topic>Multidetector Computed Tomography</topic><topic>Muscle, Skeletal - diagnostic imaging</topic><topic>Muscle, Skeletal - physiopathology</topic><topic>Neoplasm Staging</topic><topic>Oncology</topic><topic>Preoperative Period</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>ROC Curve</topic><topic>Surgery</topic><topic>Surgical Oncology</topic><topic>Survival Rate</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okumura, Shinya</creatorcontrib><creatorcontrib>Kaido, Toshimi</creatorcontrib><creatorcontrib>Hamaguchi, Yuhei</creatorcontrib><creatorcontrib>Kobayashi, Atsushi</creatorcontrib><creatorcontrib>Shirai, Hisaya</creatorcontrib><creatorcontrib>Fujimoto, Yasuhiro</creatorcontrib><creatorcontrib>Iida, Taku</creatorcontrib><creatorcontrib>Yagi, Shintaro</creatorcontrib><creatorcontrib>Taura, Kojiro</creatorcontrib><creatorcontrib>Hatano, Etsuro</creatorcontrib><creatorcontrib>Okajima, Hideaki</creatorcontrib><creatorcontrib>Uemoto, Shinji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of surgical oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okumura, Shinya</au><au>Kaido, Toshimi</au><au>Hamaguchi, Yuhei</au><au>Kobayashi, Atsushi</au><au>Shirai, Hisaya</au><au>Fujimoto, Yasuhiro</au><au>Iida, Taku</au><au>Yagi, Shintaro</au><au>Taura, Kojiro</au><au>Hatano, Etsuro</au><au>Okajima, Hideaki</au><au>Uemoto, Shinji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma</atitle><jtitle>Annals of surgical oncology</jtitle><stitle>Ann Surg Oncol</stitle><addtitle>Ann Surg Oncol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>24</volume><issue>4</issue><spage>1037</spage><epage>1045</epage><pages>1037-1045</pages><issn>1068-9265</issn><eissn>1534-4681</eissn><abstract>Background Decrease in skeletal muscle mass and function, known as sarcopenia, is associated with poor prognosis. Visceral fat accumulation also is related to mortality. This study investigated the impact of preoperative skeletal muscle mass, muscle quality, and visceral adiposity on outcomes in patients undergoing resection of intrahepatic cholangiocarcinoma (ICC). Methods A retrospective analysis was performed of 109 patients undergoing resections of ICC between January 2004 and April 2015. Skeletal muscle mass [skeletal muscle index (SMI)], skeletal muscle quality [muscle attenuation (MA)], and visceral adiposity [visceral to subcutaneous adipose tissue area ratio (VSR)] were measured on preoperative computed tomography images. The impacts of these parameters on outcomes after ICC resections were analyzed. Results The overall survival rates were significantly lower in patients with low SMI ( P  = 0.002), low MA ( P  = 0.032), and high VSR ( P  = 0.026) compared with patients with high SMI, high MA, and low VSR, respectively. With multivariate analyses, in patients with stage I–III, low SMI (hazard ratio (HR) 3.29, P  = 0.003) and low MA (HR 2.86, P  = 0.010) were revealed as independent significant risk factors for mortality. In patients with stage IV, none of these parameters was identified as risk factors, with only the absence of adjuvant chemotherapy identified as an independent risk factor for mortality (HR 5.92, P  = 0.001). Conclusions Although stage was the most important factor, low skeletal muscle mass and quality were closely related to mortality after resection of ICC in patients with stage I–III.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>27837297</pmid><doi>10.1245/s10434-016-5668-3</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1068-9265
ispartof Annals of surgical oncology, 2017-04, Vol.24 (4), p.1037-1045
issn 1068-9265
1534-4681
language eng
recordid cdi_proquest_miscellaneous_1839121441
source MEDLINE; SpringerLink Journals
subjects Aged
Area Under Curve
Bile Duct Neoplasms - pathology
Bile Duct Neoplasms - surgery
Bile Ducts, Intrahepatic
Cholangiocarcinoma - pathology
Cholangiocarcinoma - surgery
Disease-Free Survival
Female
Hepatobiliary Tumors
Humans
Intra-Abdominal Fat - diagnostic imaging
Male
Medicine
Medicine & Public Health
Middle Aged
Multidetector Computed Tomography
Muscle, Skeletal - diagnostic imaging
Muscle, Skeletal - physiopathology
Neoplasm Staging
Oncology
Preoperative Period
Retrospective Studies
Risk Factors
ROC Curve
Surgery
Surgical Oncology
Survival Rate
Treatment Outcome
title Impact of Skeletal Muscle Mass, Muscle Quality, and Visceral Adiposity on Outcomes Following Resection of Intrahepatic Cholangiocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T12%3A03%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20Skeletal%20Muscle%20Mass,%20Muscle%20Quality,%20and%20Visceral%20Adiposity%20on%20Outcomes%20Following%20Resection%20of%20Intrahepatic%20Cholangiocarcinoma&rft.jtitle=Annals%20of%20surgical%20oncology&rft.au=Okumura,%20Shinya&rft.date=2017-04-01&rft.volume=24&rft.issue=4&rft.spage=1037&rft.epage=1045&rft.pages=1037-1045&rft.issn=1068-9265&rft.eissn=1534-4681&rft_id=info:doi/10.1245/s10434-016-5668-3&rft_dat=%3Cproquest_cross%3E1839121441%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1874628133&rft_id=info:pmid/27837297&rfr_iscdi=true